Valence Advantage Life Sciences

Valence Advantage Life Sciences is a New York-based venture capital firm that specializes in growth-stage investments within the life sciences and healthcare sectors. The firm provides strategic capital to companies with late-stage clinical assets or those transitioning into commercial operations across biotechnology, specialty pharmaceuticals, and medical technology. Valence Advantage Life Sciences focuses on partnering with experienced management teams to accelerate the development of innovative therapies that address significant unmet medical needs. Their investment portfolio has historically included notable positions in companies such as Madrigal Pharmaceuticals and X4 Pharmaceuticals. The firm was established by the former life science investment team from Caxton Associates.